Asanga Halangoda, Director of Life Science at Merck Philippines, discusses the company’s impressive recent market performance, the importance of innovation in maintaining product pipeline, and the bright future of the affiliate’s role in the company’s emerging market portfolio.
As an introduction to our readers, could you please give us an overview of your professional background?
The overriding goal was to improve the market performance in the Philippines and to deliver on growth expectations
